Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section
906 of the Sarbanes-Oxley Act of 2002

In connection  with this annual report on Form 10-K of Cellegy  Pharmaceuticals,
Inc. (the  "Company")  for the period ended December 31, 2003, as filed with the
United  States  Securities  and  Exchange  Commission  on the date  hereof  (the
"Report"),  A. Richard Juelis,  as Vice  President,  Finance and Chief Financial
Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

         iii.     The Report fully  complied with the  requirements  of sections
                  13(a) or 15(d) of the Securities Exchange Act of 1934; and

         iv.      The information  contained in the Report fairly  presents,  in
                  all material respects,  the financial Condition and results of
                  operations of the Company


                                           By: /s/ A. Richard Juelis
                                               ---------------------------------
                                               A. Richard Juelis
                                               Vice President, Finance and Chief
                                               Financial Officer
                                               Date: April 6, 2004